ICIs quick Flashcards

(43 cards)

1
Q

Waterhouse 95

A

ctla4 ko

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leach 96

A

anti ctla ab tumour rej

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hodi 2010

A

pIII antictla4 ab plateau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

robert 11

A

I+D or D+P pIII trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Robert 15

A

N vs D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Larkin 2015

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alexandrov 13

A

TMB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Snyder 2014

A

high fitness neoantigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Marabelle 2020

A

clin trial high tmb = high survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gurajao 2020

A

preprint

small no. tumour types and wrong FDA cut-off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Le 2015

A

MMRd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Zaretsky 2016

A

specific jak mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chowell 2018

A

pt germline gen

HLA-I het

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ttopalian 2012

A

PD1 ex as pred of pt resp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sunshine and Taube 2015

A

PD1 not a good marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tumeh 2014

A

TIL densty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

De Henau 2016

A

MDSCs and Pi3Ky inhibitors

19
Q

Matson 2018

20
Q

Papadopoulos 2019

21
Q

Ribas 2017

A

oncolytic virus

22
Q

Valero 20211

23
Q

ctla4 ko

A

Waterhouse 95

24
Q

anti ctla ab tumour rej

25
pIII antictla4 ab plateau
hodi 2010
26
I+D or D+P pIII trial
robert 11
27
N vs D
Robert 15
28
COMB
Larkin 2015
29
TMB
Alexandrov 13
30
high fitness neoantigens
Snyder 2014
31
clin trial high tmb = high survival
Marabelle 2020
32
preprint small no. tumour types and wrong FDA cut-off
Gurajao 2020
33
MMRd
Le 2015
34
specific jak mutations
Zaretsky 2016
35
pt germline gen HLA-I het
Chowell 2018
36
PD1 ex as pred of pt resp
ttopalian 2012
37
PD1 not a good marker
Sunshine and Taube 2015
38
TIL densty
Tumeh 2014
39
MDSCs and Pi3Ky inhibitors
De Henau 2016
40
microbiota
Matson 2018
41
LAG-3
Papadopoulos 2019
42
oncolytic virus
Ribas 2017
43
N:L ratio
Valero 20211